DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect of Preoperative Duloxetine on Quality of Recovery After Outpatient Laparoscopic Surgery

Information source: Northwestern University
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Quality of Recovery; Gynecologic Surgery; Laparoscopy

Intervention: duloxetine (Drug); placebo (Drug)

Phase: Phase 4

Status: Not yet recruiting

Sponsored by: Northwestern University

Summary

The objective of this study is to determine the effect of preoperative duloxetine on postoperative quality of recovery after ambulatory surgery, specifically laparoscopic gynecological surgery.

Clinical Details

Official title: Effect of Preoperative Duloxetine on Quality of Recovery After Outpatient Laparoscopic Surgery

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: QOR-40 global score

Secondary outcome: intraoperative opioid consumption

Detailed description: It has been demonstrated that female patients have poor quality of surgical recovery compared to male patients. 1 Increased sensitivity to pain and increased susceptibility to postoperative nausea and vomiting have been attributed as causal factors. 2, 3 Currently, few strategies have been shown to improve quality of recovery in female patients undergoing laparoscopic hysterectomy. 4 A better recovery in female patients undergoing outpatient laparoscopy is particularly desirable since those patients do not have access to potent intravenous medications and nursing support after hospital discharge. In addition, pain after ambulatory surgery remains an unsolved problem in The United States and Europe. 5,6 It is associated with delayed hospital discharge and it can result to an increased opioid consumption with adverse side effects. The concept of multimodal analgesic technique was introduced more than 15 years ago and several techniques have been studied over the years including NSAIDs, acetaminophen, membrane stabilizers, ketamine, and local and regional anesthetic techniques. 7,8 Both serotonin and norepinephrine have involvement in modulation of pain mechanisms in the central nervous system. Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor that has been used for mitigation of pain in such conditions as chronic musculoskeletal pain, diabetic peripheral neuropathic pain, post-herpetic neuralgia, and fibromyalgia. 9,10 Duloxetine was also found to reduce postoperative morphine requirements in patients undergoing knee replacement surgery. 11 The MQOR 40 is a validated instrument that was specifically design to evaluate patient recovery after anesthesia and surgery. 12 This instrument can be particularly valid to examine interventions which affect different spheres of patient recovery as is the case of duloxetine. A suicidal behavior questionnaire (SBQ-R) will be used to screen for suicidal risk among potential subjects. If any subject exhibits suicidal ideation as a result of scoring high on the questionnaire, there surgeon and/or primary care provider will be notified by the principal investigator. The objective of this study is to determine the effect of preoperative duloxetine on postoperative quality of recovery after ambulatory surgery. Significance: Use of preoperative duloxetine may improve patient's quality of recovery, decrease postoperative pain, opioid consumption and opioid related side effects after ambulatory surgery.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- outpatient gynecological laparoscopy

- ASA PS 1 and 2

- fluent in English

Exclusion Criteria:

- history of allergy to duloxetine, history of chronic opioid use, pregnant patients,

preoperative SSRI or SNRI use, prolonged QT interval on ECG

Locations and Contacts

Additional Information

Starting date: August 2015
Last updated: August 11, 2015

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017